AstraZeneca strikes $40 million AI drug discovery deal with insitro | Reuters

ReutersView source article

Part of story

AstraZeneca partners with insitro on $40 million AI drug discovery deal

AstraZeneca has teamed up with AI biotech company insitro to discover and develop new treatments for difficult-to-treat liver and heart conditions, with the British drugmaker announcing the partnership on Tuesday.

Oct 15, 20262 sourcesLongevity biotech founders AI for developers

AstraZeneca partners with insitro on $40 million AI drug discovery deal

Other sources for this story

The Wall Street Journal

AstraZeneca strikes $40 million AI drug discovery deal with insitro | Reuters

Part of story

AstraZeneca partners with insitro on $40 million AI drug discovery deal

Other sources for this story

AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

AstraZeneca strikes $40 million AI drug discovery deal with insitro | Reuters

Part of story

AstraZeneca partners with insitro on $40 million AI drug discovery deal

Other sources for this story

AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro